NASDAQ: SGRYSurgery Partners Inc Stock
$16.40-0.37 (-2.21%)
Updated Jul 10, 2026
SGRY Price
$16.40
Fair Value Price
N/A
Market Cap
$2.14B
52 Week Low
$11.41
52 Week High
$24.10
P/E
-27.8x
P/B
1.27x
P/S
0.46x
PEG
N/A
Dividend Yield
N/A
Revenue
$3.34B
Earnings
-$76.10M
Gross Margin
22.8%
Operating Margin
6.59%
Profit Margin
-2.3%
Debt to Equity
2.93
Operating Cash Flow
$280M
Beta
1.56
Next Earnings
Aug 4, 2026
Ex-Dividend
N/A
Next Dividend
N/A
SGRY Overview
Surgery Partners, Inc. operates a nationwide network of surgical facilities and associated medical services across the United States. Its business is categorized into two segments: Surgical Facility Services and Ancillary Services. These surgical venues include both ambulatory surgery centers and dedicated surgical hospitals, delivering non-urgent surgical procedures across various specialties such as gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The surgical hospitals additionally offer comprehensive ancillary services, including diagnostic imaging, pharmacy, laboratory, obstetrics, oncology, physical therapy, and wound care. The dedicated Ancillary Services segment further encompasses multi-specialty physician practices, urgent care facilities, and anesthesia services. By December 31, 2021, the company's portfolio consisted of 126 surgical facilities—specifically, 108 ambulatory surgical centers and 18 surgical hospitals—situated across 31 states. Founded in 2004, Surgery Partners, Inc. maintains its headquarters in Brentwood, Tennessee.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SGRY's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +5.11% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
A
SGRY
Ranked#31 of 43
Ranked#31 of 43
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $26.27 | A | |
| $32.37 | A | |
| $9.70 | A |
Be the first to know about important SGRY news, forecast changes, insider trades & much more!
SGRY News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SGRY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SGRY is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SGRY is good value based on its book value relative to its share price (1.27x), compared to the US Medical Care Facilities industry average (5.4x)
P/B vs Industry Valuation
SGRY is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more SGRY due diligence checks available for Premium users.
Valuation
SGRY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-27.8x
Industry
16.86x
Market
12.99x
SGRY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.27x
Industry
5.4x
SGRY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SGRY's financial health
Profit margin
Revenue
$810.9M
Net Income
-$35.9M
Profit Margin
-4.4%
SGRY's Earnings (EBIT) of $220.20M... subscribe to Premium to read more.
Interest Coverage Financials
SGRY's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.0B
Liabilities
$4.9B
Debt to equity
2.93
SGRY's short-term assets ($1.08B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SGRY's long-term liabilities ($4.36B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SGRY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SGRY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$11.7M
Investing
-$13.4M
Financing
-$55.9M
SGRY's operating cash flow ($280.00M)... subscribe to Premium to read more.
Debt Coverage Financials
SGRY vs Medical Care Facility Stocks
Surgery Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.